Integre Asset Management’s Pfizer PFE Stock Holding History

Integre Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,130	Closed	-$108K	–	146
2017 Q4	$108K	Sell	3,130 -3,207	-51%	-$109K	0.06%	155
2017 Q3	$215K	Hold	6,337	–	–	0.14%	91
2017 Q2	$202K	Hold	6,337	–	–	0.12%	99
2017 Q1	$206K	Buy	+6,337	New	+$200K	0.12%	107
2016 Q3	–	Sell	-6,733	Closed	-$225K	–	138
2016 Q2	$225K	Sell	6,733 -8,427	-56%	-$269K	0.08%	117
2016 Q1	$426K	Buy	+15,160	New	+$433K	0.13%	102

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Integre Asset Management's PFE Position: Q1 2018 in Review

Integre Asset Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 3,130 shares — an estimated $108K sold.

Integre Asset Management first reported a position in PFE in Q1 2016 and held it in 6 quarters. The position peaked at $426K in Q1 2016. 2,231 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Integre Asset Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
Integre Asset Management sold 3,130 Pfizer shares in Q1 2018, an estimated $108K.
Integre Asset Management first reported a position in Pfizer in Q1 2016 and held it in 6 quarters.
Integre Asset Management's Pfizer position peaked at $426K in Q1 2016.
2,231 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Integre Asset Management's 13F filing for Q1 2018, filed 16 May 2018.